PuraMatrix™ facilitates bone regeneration in bone defects of calvaria in mice

Haruo Misawa, Naoya Kobayashi, Alejandro Soto-Gutierrez, Yong Chen, Aki Yoshida, Jorge David Rivas-Carrillo, Nalu Navarro-Alvarez, Kimiaki Tanaka, Atsushi Miki, Jiro Takei, Tadayoshi Ueda, Masato Tanaka, Hirosuke Endo, Noriaki Tanaka, Toshihumi Ozaki

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Artificial bones have often used for bone regeneration due to their strength, but they cannot provide an adequate environment for cell penetration and settlement. We therefore attempted to explore various materials that may allow the cells to penetrate and engraft in bone defects. PuraMatrix™ is a self-assembling peptide scaffold that produces a nanoscale environment allowing both cellular penetration and engraftment. The objective of this study was to investigate the effect of PuraMatrix™ on bone regeneration in a mouse bone defect model of the calvaria. Matrigel™ was used as a control. The expression of bone-related genes (alkaline phosphatase, Runx2, and Osterix) in the PuraMatrix™-injected bone defects was stronger than that in the Matrigel™-injected defects. Soft X-ray radiographs revealed that bony bridges were clearly observed in the defects treated with PuraMatrix™, but not in the Matrigel™-treated defects. Notably, PuraMatrix™ treatment induced mature bone tissue while showing cortical bone medullary cavities. The area of newly formed bones at the site of the bone defects was 1.38-fold larger for PuraMatrix™ than Matrigel™. The strength of the regenerated bone was 1.72-fold higher for PuraMatrix™ (146.0 g) than for Matrigel™ (84.7 g). The present study demonstrated that PuraMatrix™ injection favorably induced functional bone regeneration.

Original languageEnglish
Pages (from-to)903-910
Number of pages8
JournalCell Transplantation
Volume15
Issue number10
DOIs
Publication statusPublished - 2006

Fingerprint

Bone Regeneration
Skull
Bone
Bone and Bones
Defects
RADA16-I
Alkaline Phosphatase
Phosphatases
X-Rays
matrigel
Scaffolds (biology)
Peptides
Injections

Keywords

  • Bone regeneration
  • Calvaria
  • Matrigel™
  • PuraMatrix™

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation

Cite this

Misawa, H., Kobayashi, N., Soto-Gutierrez, A., Chen, Y., Yoshida, A., Rivas-Carrillo, J. D., ... Ozaki, T. (2006). PuraMatrix™ facilitates bone regeneration in bone defects of calvaria in mice. Cell Transplantation, 15(10), 903-910. https://doi.org/10.3727/000000006783981369

PuraMatrix™ facilitates bone regeneration in bone defects of calvaria in mice. / Misawa, Haruo; Kobayashi, Naoya; Soto-Gutierrez, Alejandro; Chen, Yong; Yoshida, Aki; Rivas-Carrillo, Jorge David; Navarro-Alvarez, Nalu; Tanaka, Kimiaki; Miki, Atsushi; Takei, Jiro; Ueda, Tadayoshi; Tanaka, Masato; Endo, Hirosuke; Tanaka, Noriaki; Ozaki, Toshihumi.

In: Cell Transplantation, Vol. 15, No. 10, 2006, p. 903-910.

Research output: Contribution to journalArticle

Misawa, H, Kobayashi, N, Soto-Gutierrez, A, Chen, Y, Yoshida, A, Rivas-Carrillo, JD, Navarro-Alvarez, N, Tanaka, K, Miki, A, Takei, J, Ueda, T, Tanaka, M, Endo, H, Tanaka, N & Ozaki, T 2006, 'PuraMatrix™ facilitates bone regeneration in bone defects of calvaria in mice', Cell Transplantation, vol. 15, no. 10, pp. 903-910. https://doi.org/10.3727/000000006783981369
Misawa H, Kobayashi N, Soto-Gutierrez A, Chen Y, Yoshida A, Rivas-Carrillo JD et al. PuraMatrix™ facilitates bone regeneration in bone defects of calvaria in mice. Cell Transplantation. 2006;15(10):903-910. https://doi.org/10.3727/000000006783981369
Misawa, Haruo ; Kobayashi, Naoya ; Soto-Gutierrez, Alejandro ; Chen, Yong ; Yoshida, Aki ; Rivas-Carrillo, Jorge David ; Navarro-Alvarez, Nalu ; Tanaka, Kimiaki ; Miki, Atsushi ; Takei, Jiro ; Ueda, Tadayoshi ; Tanaka, Masato ; Endo, Hirosuke ; Tanaka, Noriaki ; Ozaki, Toshihumi. / PuraMatrix™ facilitates bone regeneration in bone defects of calvaria in mice. In: Cell Transplantation. 2006 ; Vol. 15, No. 10. pp. 903-910.
@article{d10ea17395234d3e87da12d6bfd8ba34,
title = "PuraMatrix™ facilitates bone regeneration in bone defects of calvaria in mice",
abstract = "Artificial bones have often used for bone regeneration due to their strength, but they cannot provide an adequate environment for cell penetration and settlement. We therefore attempted to explore various materials that may allow the cells to penetrate and engraft in bone defects. PuraMatrix™ is a self-assembling peptide scaffold that produces a nanoscale environment allowing both cellular penetration and engraftment. The objective of this study was to investigate the effect of PuraMatrix™ on bone regeneration in a mouse bone defect model of the calvaria. Matrigel™ was used as a control. The expression of bone-related genes (alkaline phosphatase, Runx2, and Osterix) in the PuraMatrix™-injected bone defects was stronger than that in the Matrigel™-injected defects. Soft X-ray radiographs revealed that bony bridges were clearly observed in the defects treated with PuraMatrix™, but not in the Matrigel™-treated defects. Notably, PuraMatrix™ treatment induced mature bone tissue while showing cortical bone medullary cavities. The area of newly formed bones at the site of the bone defects was 1.38-fold larger for PuraMatrix™ than Matrigel™. The strength of the regenerated bone was 1.72-fold higher for PuraMatrix™ (146.0 g) than for Matrigel™ (84.7 g). The present study demonstrated that PuraMatrix™ injection favorably induced functional bone regeneration.",
keywords = "Bone regeneration, Calvaria, Matrigel™, PuraMatrix™",
author = "Haruo Misawa and Naoya Kobayashi and Alejandro Soto-Gutierrez and Yong Chen and Aki Yoshida and Rivas-Carrillo, {Jorge David} and Nalu Navarro-Alvarez and Kimiaki Tanaka and Atsushi Miki and Jiro Takei and Tadayoshi Ueda and Masato Tanaka and Hirosuke Endo and Noriaki Tanaka and Toshihumi Ozaki",
year = "2006",
doi = "10.3727/000000006783981369",
language = "English",
volume = "15",
pages = "903--910",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "10",

}

TY - JOUR

T1 - PuraMatrix™ facilitates bone regeneration in bone defects of calvaria in mice

AU - Misawa, Haruo

AU - Kobayashi, Naoya

AU - Soto-Gutierrez, Alejandro

AU - Chen, Yong

AU - Yoshida, Aki

AU - Rivas-Carrillo, Jorge David

AU - Navarro-Alvarez, Nalu

AU - Tanaka, Kimiaki

AU - Miki, Atsushi

AU - Takei, Jiro

AU - Ueda, Tadayoshi

AU - Tanaka, Masato

AU - Endo, Hirosuke

AU - Tanaka, Noriaki

AU - Ozaki, Toshihumi

PY - 2006

Y1 - 2006

N2 - Artificial bones have often used for bone regeneration due to their strength, but they cannot provide an adequate environment for cell penetration and settlement. We therefore attempted to explore various materials that may allow the cells to penetrate and engraft in bone defects. PuraMatrix™ is a self-assembling peptide scaffold that produces a nanoscale environment allowing both cellular penetration and engraftment. The objective of this study was to investigate the effect of PuraMatrix™ on bone regeneration in a mouse bone defect model of the calvaria. Matrigel™ was used as a control. The expression of bone-related genes (alkaline phosphatase, Runx2, and Osterix) in the PuraMatrix™-injected bone defects was stronger than that in the Matrigel™-injected defects. Soft X-ray radiographs revealed that bony bridges were clearly observed in the defects treated with PuraMatrix™, but not in the Matrigel™-treated defects. Notably, PuraMatrix™ treatment induced mature bone tissue while showing cortical bone medullary cavities. The area of newly formed bones at the site of the bone defects was 1.38-fold larger for PuraMatrix™ than Matrigel™. The strength of the regenerated bone was 1.72-fold higher for PuraMatrix™ (146.0 g) than for Matrigel™ (84.7 g). The present study demonstrated that PuraMatrix™ injection favorably induced functional bone regeneration.

AB - Artificial bones have often used for bone regeneration due to their strength, but they cannot provide an adequate environment for cell penetration and settlement. We therefore attempted to explore various materials that may allow the cells to penetrate and engraft in bone defects. PuraMatrix™ is a self-assembling peptide scaffold that produces a nanoscale environment allowing both cellular penetration and engraftment. The objective of this study was to investigate the effect of PuraMatrix™ on bone regeneration in a mouse bone defect model of the calvaria. Matrigel™ was used as a control. The expression of bone-related genes (alkaline phosphatase, Runx2, and Osterix) in the PuraMatrix™-injected bone defects was stronger than that in the Matrigel™-injected defects. Soft X-ray radiographs revealed that bony bridges were clearly observed in the defects treated with PuraMatrix™, but not in the Matrigel™-treated defects. Notably, PuraMatrix™ treatment induced mature bone tissue while showing cortical bone medullary cavities. The area of newly formed bones at the site of the bone defects was 1.38-fold larger for PuraMatrix™ than Matrigel™. The strength of the regenerated bone was 1.72-fold higher for PuraMatrix™ (146.0 g) than for Matrigel™ (84.7 g). The present study demonstrated that PuraMatrix™ injection favorably induced functional bone regeneration.

KW - Bone regeneration

KW - Calvaria

KW - Matrigel™

KW - PuraMatrix™

UR - http://www.scopus.com/inward/record.url?scp=33846597141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846597141&partnerID=8YFLogxK

U2 - 10.3727/000000006783981369

DO - 10.3727/000000006783981369

M3 - Article

VL - 15

SP - 903

EP - 910

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 10

ER -